The Paterson Institute for Cancer Research is a leading cancer research institute within The University of Manchester, core funded by Cancer Research UK, the largest independent cancer research organisation in the world.

Research spans the whole spectrum of cancer research, from programmes investigating molecular and cellular basis of cancer, to those focussed on translational research and development of therapeutics.

The roles of ATF2 (activating transcription factor 2) in tumorigenesis. Gozdecka M, Breitwieser W. Biochem Soc Trans. 2012 Feb 1;40(1):230-4.

A Pilot Study Assessing the Prognostic Value of CK18 and nDNA Biomarkers in Severe Sepsis Patients. Moore DJ, Greystoke A, Butt F, Wurthner J, Growcott J, Hughes A, Dive C.Clin Drug Investig. 2012 Jan 4. [Epub ahead of print]